Long-term outcomes in rapamycin on renal allograft function: a 30-year follow-up from a single-center experience
In this study, a 30-year follow-up was performed in a single center, and a total graft 20-year survival rate of 20.9% was reported. The prognostic model and subgroup analysis suggested that FK506 combined with rapamycin could effectively improve the prognosis of renal transplantation, which could be explained by reduced acute rejection and less vascular inflammation.
Authors
- Zijie Wang (ORCID: https://orcid.org/0000-0001-7974-7075)
- Yisheng Ji
- Fei Shuang (ORCID: https://orcid.org/0000-0001-6333-9237)
- Hao Chen (ORCID: https://orcid.org/0000-0002-2680-6921)
- Zhijian Han
- Li Sun
- Min Gu (ORCID: https://orcid.org/0000-0002-1000-5249)
- Xiaobing Ju
- Ruoyun Tan (ORCID: https://orcid.org/0009-0001-2617-272X)
- Jun Tao
- Xiang Gao
Institutions
- Second Affiliated Hospital of Nanjing Medical University (CN)
- Jiangsu Province Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- BMC Nephrology
- Published
- 2024-09-18
- DOI
- https://doi.org/10.1186/s12882-024-03730-8
- Citations
- 4
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.03
Funders
- National Natural Science Foundation of China
- Government of Jiangsu Province
- Natural Science Foundation of Jiangsu Province